Hematopoietic Stem Cells Reverse Cell Damage in Neuro-muscular Disease

by Anjali Aryamvally on October 27, 2017 at 11:07 AM

Single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mouse model with a neuromuscular degenerative disease called Friedreich's ataxia (FA) halted cellular damage, says study. The study was conducted at the University of California San Diego School of Medicine and published in Science Translational Medicine .

Friedreich's ataxia is an inherited, degenerative neuromuscular disorder that initially impairs motor function, such as gait and coordination, but can lead to scoliosis, heart disease, vision loss and diabetes. Cognitive function is not affected. The disease is progressively debilitating, and ultimately requires full-time use of a wheelchair. One in 50,000 Americans has FA.

Hematopoietic Stem Cell Transplant For STAT1 Gene Mutation - Promising But Risky

First ever study to assess response to stem cell transplant in STAT1 mutation suggests that it is curative but has high incidence of graft failure and death.

‘Transplanting wildtype HSPCs into an FA mouse model, appeared to transfer wildtype FXN into deficient neurons and muscle cells.’

Tweet it Now

FA is caused by reduced expression of a mitochondrial protein called frataxin (FXN) due to a two mutated or abnormal copies of the FXN gene. In their study, Stephanie Cherqui, PhD, associate professor in the UC San Diego School of Medicine Department of Pediatrics, and colleagues used a transgenic mouse model that expresses two mutant human FXN transgenes, and exhibits the resulting progressive neurological degeneration and muscle weakness.

Human hematopoietic stem and progenitor cells (HSPCs), derived from bone marrow, have become a primary vehicle for efforts to replace or regenerate cells destroyed by a variety of diseases. Previous research by Cherqui and colleagues had shown that transplanting wildtype or normal mouse HSPCs resulted in long-term kidney, eye and thyroid preservation in a mouse model of cystinosis, another genetic disorder.

Self-Renewing Hematopoietic Stem Cells: Major Game-changer In Blood Disorder Therapy

Generation of self-renewing hematopoietic stem cells (HSC) is a major stride ahead in offering a potential cure for of several inherited and acquired blood diseases.

In this study, Cherqui's team transplanted wildtype HSPCs into an FA mouse model, reporting that the HSPCs engrafted and soon differentiated into macrophages in key regions of the mice's brain and spinal cord where they appeared to transfer wildtype FXN into deficient neurons and muscle cells.

"Transplantation of wildtype mouse HSPCs essentially rescued FA-impacted cells," said Cherqui, "Frataxin expression was restored. Mitochondrial function in the brains of the transgenic mice normalized, as did in the heart. There was also decreased skeletal muscle atrophy."

The scientists note that the mouse model is not perfect mirror of human FA. Disease progression is somewhat different and the precise pathology in mice is not fully known. However, Cherqui said the findings are encouraging and point toward a potential treatment for a disease that currently has none.

Source: Eurekalert